CIK 0001680367 · Non-accelerated filer<br>Smaller reporting company
Shattuck Labs, Inc.
Sign in to watch- Ticker
- STTK
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 812575858
- Phone
- 512-900-4690
- Business address
- 500 W. 5TH STREET, AUSTIN, TX, 78701
- Former names
- Shattuck Labs, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-06-08 | ORBIMED ADVISORS LLC Director | Conversion · Common Warrants (right to buy) | −3,073,298 | 0 | ||
| 2026-06-08 | Ashiya Mona Director | Conversion · Pre-Funded Warrants (right to buy) | +15,366,490 | 25,477,874 | ||
| 2026-06-08 | Ashiya Mona Director | Conversion · Pre-Funded Warrants (right to buy) | +3,073,298 | 5,095,575 | ||
| 2026-06-08 | Ashiya Mona Director | Conversion · Common Warrants (right to buy) | −15,366,490 | 0 | ||
| 2026-06-08 | Ashiya Mona Director | Conversion · Common Warrants (right to buy) | −3,073,298 | 0 | ||
| 2026-05-29 | Baker Daniel G. Director | Grant or award · Stock Option (Right to Buy) | +81,000 | 81,000 | ||
| 2026-05-29 | Golumbeski George Director | Grant or award · Stock Option (Right to Buy) | +81,000 | 81,000 | ||
| 2026-05-29 | Gibson Neil W Director | Grant or award · Stock Option (Right to Buy) | +81,000 | 81,000 | ||
| 2026-05-29 | Ashiya Mona Director | Grant or award · Stock Option (Right to Buy) | +81,000 | 81,000 | ||
| 2026-05-29 | SIEGALL CLAY B Director | Grant or award · Stock Option (Right to Buy) | +81,000 | 81,000 | ||
| 2026-05-29 | Boudreau Helen M Director | Grant or award · Stock Option (Right to Buy) | +81,000 | 81,000 | ||
| 2026-05-22 | SIEGALL CLAY B Director | Grant or award | +128,054 | $1.08 | $139K | 256,108 |
| 2026-05-22 | SIEGALL CLAY B Director | Option exercise · Warrants (Right to Buy) | −128,054 | 0 | ||
| 2026-05-21 | Shukla Abhinav A. Chief Technical Officer | Grant or award | +5,122 | $1.08 | $6K | 86,380 |
| 2026-05-21 | Shukla Abhinav A. Chief Technical Officer | Option exercise · Warrants (Right to Buy) | −5,122 | 0 | ||
| 2026-05-15 | Stout Stephen See Remarks | Grant or award | +12,805 | $1.08 | $14K | 93,366 |
| 2026-05-15 | Stout Stephen See Remarks | Option exercise · Warrants (Right to Buy) | −12,805 | 0 | ||
| 2026-05-12 | Neill Andrew R Chief Financial Officer | Grant or award | +64,027 | $1.08 | $69K | 292,251 |
| 2026-05-12 | Neill Andrew R Chief Financial Officer | Option exercise · Warrants (Right to Buy) | −64,027 | 0 | ||
| 2026-05-12 | Shukla Abhinav A. Chief Technical Officer | Option exercise 10b5-1 | +2,032 | $3.57 | $7K | 83,290 |
Page 2 of 7 · 121 trades